| Key Management Personnel Disclosures |
NOTE 26. KEY MANAGEMENT PERSONNEL DISCLOSURES (a) Directors and key management personnel compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Consolidated |
|
| |
|
June 30, 2026 |
|
|
June 30, 2025 |
|
|
June 30, 2024 |
|
| |
|
A$ |
|
|
A$ |
|
|
A$ |
|
| Short-term employee benefits |
|
|
3,396,698 |
|
|
|
3,401,189 |
|
|
|
2,656,821 |
|
| Long-term employee benefits |
|
|
15,853 |
|
|
|
17,028 |
|
|
|
3,861 |
|
| Post-employment benefits |
|
|
96,539 |
|
|
|
81,223 |
|
|
|
66,891 |
|
| Share-based payments |
|
|
1,453,432 |
|
|
|
905,305 |
|
|
|
1,259,571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,962,522 |
|
|
|
4,404,745 |
|
|
|
3,987,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (b) Equity instrument disclosures relating to key management personnel (i) Options provided as remuneration and shares issued on exercise of such options There were no options provided as remuneration during the fiscal years ended June 30, 2026, June 30, 2025 and June 30, 2024. (ii) Shareholding The numbers of shares in the company held during the financial year by each director and other key management personnel of the Group, including their personally related parties, are set out below. There were no shares granted during the reporting period as compensation. (iii) Ordinary Share holdings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2026 Ordinary shares |
|
Balance at start of the fiscal year |
|
|
Received during the fiscal year on exercise of performance rights |
|
|
Received during the fiscal year on the exercise of options |
|
|
Other changes during the fiscal year# |
|
|
Balance at end of the fiscal year |
|
| Dr Russell Howard |
|
|
1,417,977 |
|
|
|
300,000 |
|
|
|
— |
|
|
|
— |
|
|
|
1,717,977 |
|
| Mr Pete Meyers |
|
|
3,663,284 |
|
|
|
388,889 |
|
|
|
— |
|
|
|
— |
|
|
|
4,052,173 |
|
| Mr Marc Voigt |
|
|
13,676,945 |
|
|
|
1,200,000 |
|
|
|
— |
|
|
|
— |
|
|
|
14,876,945 |
|
| Dr Frédéric Triebel |
|
|
10,453,764 |
|
|
|
900,000 |
|
|
|
— |
|
|
|
— |
|
|
|
11,353,764 |
|
| Ms Lis Boyce |
|
|
256,621 |
|
|
|
166,667 |
|
|
|
— |
|
|
|
— |
|
|
|
423,288 |
|
| Ms Deanne Miller |
|
|
2,467,305 |
|
|
|
600,000 |
|
|
|
— |
|
|
|
(200,000 |
) |
|
|
2,867,305 |
|
| Mr Christian Mueller |
|
|
3,307,382 |
|
|
|
466,666 |
|
|
|
— |
|
|
|
— |
|
|
|
3,774,048 |
|
| Dr Stephan Winckels |
|
|
— |
|
|
|
92,935 |
|
|
|
— |
|
|
|
— |
|
|
|
92,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ordinary shares |
|
|
35,243,278 |
|
|
|
4,115,157 |
|
|
|
— |
|
|
|
(200,000 |
) |
|
|
39,158,435 |
|
| ADSs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mr Marc Voigt |
|
|
45 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
45 |
|
| Dr Frédéric Triebel |
|
|
17,061 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
17,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ADSs |
|
|
17,106 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
17,106 |
|
| # |
Other changes during the year include on market acquisitions and/or disposals. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2025 Ordinary shares |
|
Balance at start of the fiscal year |
|
|
Received during the fiscal year on exercise of performance rights |
|
|
Received during the fiscal year on the exercise of options |
|
|
Other changes during the fiscal year# |
|
|
Balance at end of the fiscal year |
|
| Dr Russell Howard |
|
|
1,113,207 |
|
|
|
304,770 |
|
|
|
— |
|
|
|
— |
|
|
|
1,417,977 |
|
| Mr Pete Meyers |
|
|
3,274,395 |
|
|
|
388,889 |
|
|
|
— |
|
|
|
— |
|
|
|
3,663,284 |
|
| Mr Marc Voigt |
|
|
11,247,445 |
|
|
|
2,400,000 |
|
|
|
— |
|
|
|
29,500 |
|
|
|
13,676,945 |
|
| Dr Frédéric Triebel |
|
|
8,653,764 |
|
|
|
1,800,000 |
|
|
|
— |
|
|
|
— |
|
|
|
10,453,764 |
|
| Ms A Anderson |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Dr F Vogl |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Mr Christian Mueller |
|
|
2,840,715 |
* |
|
|
466,667 |
* |
|
|
— |
|
|
|
— |
|
|
|
3,307,382 |
|
| Ms Lis Boyce |
|
|
— |
|
|
|
256,621 |
|
|
|
— |
|
|
|
— |
|
|
|
256,621 |
|
| Ms Deanne Miller |
|
|
2,067,305 |
|
|
|
1,200,000 |
|
|
|
— |
|
|
|
(800,000 |
) |
|
|
2,467,305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADSs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mr Marc Voigt |
|
|
45 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
45 |
|
| Dr Frédéric Triebel |
|
|
17,061 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
17,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ADSs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| # |
Other changes during the year include on market acquisitions and/or disposals. |
| * |
Shares held before being appointed as key management personnel. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2024 Ordinary shares |
|
Balance at start of the fiscal year |
|
|
Received during the fiscal year on exercise of performance rights |
|
|
Received during the fiscal year on the exercise of options |
|
|
Other changes during the fiscal year# |
|
|
Balance at end of the fiscal year |
|
| Dr Russell Howard |
|
|
1,113,207 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,113,207 |
|
| Mr Pete Meyers |
|
|
2,774,395 |
|
|
|
500,000 |
|
|
|
— |
|
|
|
— |
|
|
|
3,274,395 |
|
| Mr Marc Voigt |
|
|
11,247,445 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
11,247,445 |
|
| Dr Frédéric Triebel |
|
|
8,653,764 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,653,764 |
|
| Ms A Anderson |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Dr F Vogl |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Ms Lis Boyce |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Ms Deanne Miller |
|
|
3,267,305 |
|
|
|
— |
|
|
|
— |
|
|
|
(1,200,000 |
) |
|
|
2,067,305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADSs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mr Marc Voigt |
|
|
45 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
45 |
|
| Dr Frédéric Triebel |
|
|
17,061 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
17,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total ADSs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| # |
Other changes during the year include on market acquisitions and/or disposals. | (iv) Option holdings There were no option holdings held and no movements during the fiscal years 2026, 2025 and 2024. (v) Performance rights holdings The number of performance rights over ordinary shares in the parent entity held during the financial year by each director and other members of key management personnel of the consolidated entity, including their personally related parties, is set out below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2026 |
|
Balance at start of the fiscal year |
|
|
Granted |
|
|
Exercised |
|
|
Other Changes |
|
|
Balance at end of the fiscal year |
|
|
Vested and exercisable |
|
|
Unvested |
|
| Performance rights over ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dr Russell Howard |
|
|
100,000 |
|
|
|
1,573,646 |
|
|
|
(300,000 |
) |
|
|
— |
|
|
|
1,373,646 |
|
|
|
— |
|
|
|
1,373,646 |
|
| Mr Pete Meyers |
|
|
777,778 |
|
|
|
2,058,631 |
|
|
|
(388,889 |
) |
|
|
— |
|
|
|
2,447,520 |
|
|
|
— |
|
|
|
2,447,520 |
|
| Mr Marc Voigt |
|
|
4,800,000 |
|
|
|
— |
|
|
|
(1,200,000 |
) |
|
|
— |
|
|
|
3,600,000 |
|
|
|
— |
|
|
|
3,600,000 |
|
| Dr Frédéric Triebel |
|
|
3,600,000 |
|
|
|
— |
|
|
|
(900,000 |
) |
|
|
— |
|
|
|
2,700,000 |
|
|
|
— |
|
|
|
2,700,000 |
|
| Ms Lis Boyce |
|
|
333,334 |
|
|
|
707,232 |
|
|
|
(166,667 |
) |
|
|
— |
|
|
|
873,899 |
|
|
|
— |
|
|
|
873,899 |
|
| Ms Deanne Miller |
|
|
2,400,000 |
|
|
|
— |
|
|
|
(600,000 |
) |
|
|
— |
|
|
|
1,800,000 |
|
|
|
— |
|
|
|
1,800,000 |
|
| Mr Christian Mueller |
|
|
1,866,666 |
|
|
|
— |
|
|
|
(466,666 |
) |
|
|
— |
|
|
|
1,400,000 |
|
|
|
— |
|
|
|
1,400,000 |
|
| Dr Stephan Winckels |
|
|
— |
|
|
|
758,059 |
|
|
|
(92,935 |
) |
|
|
— |
|
|
|
665,124 |
|
|
|
— |
|
|
|
665,124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
|
13,877,778 |
|
|
|
5,097,568 |
|
|
|
(4,115,157 |
) |
|
|
— |
|
|
|
14,860,189 |
|
|
|
— |
|
|
|
14,860,189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2025 |
|
Balance at start of the fiscal year |
|
|
Granted |
|
|
Exercised |
|
|
Other Changes |
|
|
Balance at end of the fiscal year |
|
|
Vested and exercisable |
|
|
Unvested |
|
| Performance rights over ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dr Russell Howard |
|
|
404,770 |
|
|
|
— |
|
|
|
(304,770 |
) |
|
|
— |
|
|
|
100,000 |
|
|
|
— |
|
|
|
100,000 |
|
| Mr Pete Meyers |
|
|
1,166,667 |
|
|
|
— |
|
|
|
(388,889 |
) |
|
|
— |
|
|
|
777,778 |
|
|
|
— |
|
|
|
777,778 |
|
| Mr Marc Voigt |
|
|
3,600,000 |
|
|
|
3,600,000 |
|
|
|
(2,400,000 |
) |
|
|
— |
|
|
|
4,800,000 |
|
|
|
— |
|
|
|
4,800,000 |
|
| Dr Frédéric Triebel |
|
|
2,700,000 |
|
|
|
2,700,000 |
|
|
|
(1,800,000 |
) |
|
|
— |
|
|
|
3,600,000 |
|
|
|
— |
|
|
|
3,600,000 |
|
| Ms Anne Anderson |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Ms Lis Boyce |
|
|
589,955 |
|
|
|
— |
|
|
|
(256,621 |
) |
|
|
— |
|
|
|
333,334 |
|
|
|
— |
|
|
|
333,334 |
|
| Ms Deanne Miller |
|
|
1,800,000 |
|
|
|
1,800,000 |
|
|
|
(1,200,000 |
) |
|
|
— |
|
|
|
2,400,000 |
|
|
|
— |
|
|
|
2,400,000 |
|
| Mr Christian Mueller |
|
|
933,333 |
* |
|
|
1,400,000 |
* |
|
|
(466,667 |
)* |
|
|
— |
|
|
|
1,866,666 |
|
|
|
— |
|
|
|
1,866,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dr Florian Vogl |
|
|
1,343,856 |
|
|
|
— |
|
|
|
— |
|
|
|
(1,343,856 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
|
12,538,581 |
|
|
|
9,500,000 |
|
|
|
(6,816,947 |
) |
|
|
(1,343,856 |
) |
|
|
13,877,778 |
|
|
|
— |
|
|
|
13,877,778 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| * |
Performance rights held before being appointed as key management personnel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 30, 2024 |
|
Balance at start of the fiscal year |
|
|
Granted |
|
|
Exercised |
|
|
Other Changes |
|
|
Balance at end of the fiscal year |
|
|
Vested and exercisable |
|
|
Unvested |
|
| Performance rights over ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dr Russell Howard |
|
|
226,414 |
|
|
|
178,356 |
|
|
|
— |
|
|
|
— |
|
|
|
404,770 |
|
|
|
141,563 |
|
|
|
263,207 |
|
| Mr Pete Meyers |
|
|
1,666,667 |
|
|
|
— |
|
|
|
(500,000 |
) |
|
|
— |
|
|
|
1,166,667 |
|
|
|
— |
|
|
|
1,166,667 |
|
| Mr Marc Voigt |
|
|
3,600,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,600,000 |
|
|
|
1,200,000 |
|
|
|
2,400,000 |
|
| Dr Frédéric Triebel |
|
|
2,700,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,700,000 |
|
|
|
900,000 |
|
|
|
1,800,000 |
|
| Ms Anne Anderson |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Ms Lis Boyce |
|
|
— |
|
|
|
589,955 |
|
|
|
— |
|
|
|
— |
|
|
|
589,955 |
|
|
|
89,954 |
|
|
|
500,001 |
|
| Ms Deanne Miller |
|
|
1,800,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,800,000 |
|
|
|
600,000 |
|
|
|
1,200,000 |
|
| Dr Florian Vogl |
|
|
— |
|
|
|
1,343,856 |
|
|
|
— |
|
|
|
— |
|
|
|
1,343,856 |
|
|
|
— |
|
|
|
1,343,856 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
|
9,993,081 |
|
|
|
2,112,167 |
|
|
|
(500,000 |
) |
|
|
— |
|
|
|
11,605,248 |
|
|
|
2,931,517 |
|
|
|
8,673,731 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|